Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Declines By 24.9%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 18,100 shares, a drop of 24.9% from the November 15th total of 24,100 shares. Based on an average daily volume of 16,100 shares, the days-to-cover ratio is currently 1.1 days.

NLS Pharmaceutics Stock Performance

NASDAQ NLSPW traded up $0.00 on Friday, reaching $0.01. 4,000 shares of the company were exchanged, compared to its average volume of 18,160. The business’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.02. NLS Pharmaceutics has a fifty-two week low of $0.01 and a fifty-two week high of $0.10.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).